Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Monica Simonetti"'
Autor:
Francesco Lapi, Ettore Marconi, Monica Simonetti, Vincenzo Baldo, Alessandro Rossi, Aurelio Sessa, Claudio Cricelli
Publikováno v:
Expert Review of Vaccines, Vol 18, Iss 6, Pp 663-670 (2019)
Background: The higher effectiveness of MF59®-adjuvanted trivalent influenza vaccine (MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was found considering few influenza seasons, local and heterogeneous settings. Thi
Externí odkaz:
https://doaj.org/article/6d8649678f4f4624aa11a6d9be0b5b86
Autor:
Giancarlo Agnelli, Claudio Cricelli, Alexander T. Cohen, Damiano Parretti, Francesco Lapi, Andrea Fontanella, Ettore Marconi, Monica Simonetti, Francesco Dentali, Gualberto Gussoni, Luca Parretti, Mauro Campanini
Publikováno v:
Thrombosis and Haemostasis. 120:692-701
Background Most episodes of venous thromboembolism (VTE) occurred in primary care. To date, no score potentially able to identify those patients who may deserve an antithrombotic prophylaxis has been developed. Aim The objective of this study is to d
Autor:
Enrico Dainese, Clotilde B. Angelucci, Monica Simonetti, Mauro Maccarrone, Daniel Tortolani, Annalaura Sabatucci
Publikováno v:
Cannabis and Cannabinoid Research
Background: Fatty acid amide hydrolase (FAAH) is a membrane-bound homodimeric enzyme that gets in contact with a lipophilic substrate in the lipid bilayer, and then cleaves it into water soluble products. FAAH plays a critical role in modulating in v
Autor:
Beatrice Dufrusine, Sergio Oddi, Gianni De Fabritiis, Filomena Fezza, Mauro Maccarrone, Monica Simonetti, Annalaura Sabatucci, Clotilde B. Angelucci, Enrico Dainese, Alice Ballone
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Fatty acid amide hydrolase (FAAH) is a membrane-bound homodimeric enzyme that in vivo controls content and biological activity of N-arachidonoylethanolamine (AEA) and other relevant bioactive lipids termed endocannabinoids. Parallel orientation of FA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9646d9d64f2430fb4a6efc14ca337b5
Autor:
Klara Berencsi, J van der Lei, Monica Simonetti, Carlen Reyes, N Deltour, Daniel Prieto-Alhambra, P Rijnbeek, K Marinier, Miriam C. J. M. Sturkenboom, M S Ali, S Perez-Guthann, Francesco Lapi, Lars Pedersen
Publikováno v:
Osteoporosis International, 31(12), 2425-2438. Springer London
Ali, M S, Berencsi, K, Marinier, K, Deltour, N, Perez-Guthann, S, Pedersen, L, Rijnbeek, P, Lapi, F, Simonetti, M, Reyes, C, Van der Lei, J, Sturkenboom, M & Prieto-Alhambra, D 2020, ' Comparative cardiovascular safety of strontium ranelate and bisphosphonates : a multi-database study in 5 EU countries by the EU-ADR Alliance ', Osteoporosis International, vol. 31, no. 12, pp. 2425-2438 . https://doi.org/10.1007/s00198-020-05580-0
Ali, M S, Berencsi, K, Marinier, K, Deltour, N, Perez-Guthann, S, Pedersen, L, Rijnbeek, P, Lapi, F, Simonetti, M, Reyes, C, Van der Lei, J, Sturkenboom, M & Prieto-Alhambra, D 2020, ' Comparative cardiovascular safety of strontium ranelate and bisphosphonates : a multi-database study in 5 EU countries by the EU-ADR Alliance ', Osteoporosis International, vol. 31, no. 12, pp. 2425-2438 . https://doi.org/10.1007/s00198-020-05580-0
Summary: Strontium ranelate use, compared with oral bisphosphonates, is not associated with increased risk of AMI in patients with no contraindications for SR use. However, current strontium ranelate (compared with current bisphosphonate) appears ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68faccae9ccf8a05abde16e2efb73ee2
https://pure.eur.nl/en/publications/68c046be-6eff-48de-b972-4cbb788382ee
https://pure.eur.nl/en/publications/68c046be-6eff-48de-b972-4cbb788382ee
Autor:
Nicoletta Cassano, Claudio Cricelli, Francesco Lapi, Iacopo Cricelli, Monica Simonetti, Gino A. Vena
Publikováno v:
Clinical Drug Investigation. 37:755-762
We evaluated the prescription appropriateness of cyproterone acetate in combination with ethinylestradiol (CPA/EE) in a primary care setting before and after the 2013 European Medicines Agency’s (EMA) recommendation relating to the risk profile of
Autor:
Andrea Fanelli, Francesco Lapi, Iacopo Cricelli, Monica Simonetti, Claudio Cricelli, Alfredo Vannacci, Pierangelo Lora Aprile, Niccolò Lombardi, Diego Fornasari
Publikováno v:
Current Medical Research and Opinion. 33:1141-1148
There are contrasting positions concerning the benefit-risk ratio of acetaminophen use for osteoarthritis (OA)-related pain. To clarify the effectiveness of acetaminophen or acetaminophen-codeine combinations according to their regimen of use, we eva
Autor:
Francesco Lapi, Alessandro Bartoloni, Marco Tuccori, Claudio Cricelli, Alessandro Rossi, Giampaolo Corti, Corrado Blandizzi, Stefania Mantarro, Monica Simonetti, Iacopo Cricelli, Alice Capogrosso Sansone, Alfonso Bellia, Leonardo Baiocchi
Publikováno v:
European Journal of Gastroenterology & Hepatology. 29:271-276
BACKGROUND/AIM In the era of direct-acting antiviral medications, which can cure the hepatitis C virus (HCV) infection, the actual epidemiology of this condition in the general population is still unclear. We therefore aimed to estimate the prevalenc
Autor:
Monica Simonetti, Claudio Cricelli, Damiano Parretti, Alessandra Bettiol, Francesco Lapi, Ettore Marconi, Niccolò Lombardi, Giada Crescioli, Alfredo Vannacci
Publikováno v:
The American journal of cardiology. 125(9)
Combination therapies are often needed to modify the concomitant risk factors for cardiovascular disease. Nonadherence to cardiovascular medications is a relevant concern, especially in polytherapy. We conducted a population-based, cohort study with
Autor:
Adriana Masotti, Monica Simonetti, Francesco Lapi, Ettore Marconi, Ovidio Brignoli, Miriam Levi, F. Heiman, Claudio Cricelli, V. Pegoraro, Maurizio Cancian
Publikováno v:
Annals of hematology. 98(7)
Iron-deficiency anemia (IDA) was the main condition contributing to higher rates of years lived with disabilities in women in 2016. To date, few studies have investigated gender differences in determinants of IDA in Europe. The aim of the present stu